Clinical trial

A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.

NCT02178124

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-07-01

PhasePHASE1

Study timeline

Study start (unknown)2014-07-01Date precision: month

Registry last updated2015-03-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

DonepezilDRUG · verified · RxNorm: donepezil

placeboDRUG

Sponsors & collaborators

Icure Pharmaceutical Inc.lead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02178124 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.